A role for monomeric c-reactive protein in regulation of angiogenesis, endothelial cell inflammation and thrombus formation in cardiovascular/cerebrovascular disease?

Histology and Histopathology

Volumn 24, Issue 11, 2009, Pages 1473-1478

  Slevin, M ^a   Krupinski, J ^b  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

Angiogenesis; C reactive protein; Monomeric; Signal transduction

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ANIMAL; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; ENDOTHELIUM CELL; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; THROMBOSIS;

ANIMALS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; THROMBOSIS;

EID: 73349124515     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Bello G., Cailotto F., Hanriot D., Kolopp-Sarda M.N., Latger-Cannard V., Hess K., Zannard F., Longrois D. and Ropars A. (2008). C-reactive protein (CRP) increases VEGF-A expression in monocytic cells via a PI3-kinase and ERK1/2 signaling dependent pathway. Atherosclerosis 200, 286-293.
2. Boguslawski G., McGlynn P.W., Potempa L.A., Filep J.G. and Labarrere C.A. (2007). Conduct unbecoming: CRP interactions with a broad range of protein molecules. J. Heart and Lung Transplantation. 26, 705-713.
3. Brunetti N.D., Padalino R., De Gennaro L., Cuculo A., Ziccardi L., Pellegrino P.L. and Biase MD. (2008). Acute phase proteins activation in subjects with coronary atherosclerosis and micro-vessel coronary circulation impairment. J. Thromb. Thrombolysis. (in press).
4. Calabro P., Willerson J.T. and Yeh E.T. (2003). Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108, 1930-1932.
5. Cirillo P., Golino P., Calabrò P., Calì G., Ragni M., De Rosa S., Cimmino G., Pacileo M., De Palma R., Forte L., Gargiulo A., Corigliano F.G., Angri V., Spagnuolo R., Nitsch L., Chiariello M. (2005). C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc. Res. 68, 47-55.
6. Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eriksdottir G., Rumley A., Lowe G.D., Pepys M.B. and Gudnason V. (2004). Creactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N. Engl. J. Med. 350,1387-1397.
7. Dasu M.R., Devaraj S., Du Clos T.W. and Jialal I. (2007). The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells. J. Lipid Res. 48, 509-512.
8. De Ferranti S.D. and Rifai N. (2007) C-reactive protein: a non-traditional serum marker of cardiovascular disease. Cardiovasc. Pathol. 16, 14-21.
9. Diehl E.E., Haines G.K., Radosevich J.A. and Potempa L.A. (2000). Immunohistochemical localization of mCRP antigen in normal vascular tissue. Am. J. Med. Sci. 319, 79-83.
10. Doyle B. and Caplice N. (2007). Plaque neovascularization and antiangiogenic therapy for atherosclerosis. J. Am. Coll. Cardiol. 49, 2073-2080.
11. Jabs W.J., Theissing E., Nitschke M., Bechtel J.F., Duchrow M., Mohamed S., Jahrbeck B., Sievers H.H., Steinhoff J. and Bartels C. (2003). Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation 108, 1428-1431.
12. Ji S.R., Ma L., Bai C.J., Shi J.M., Li H.Y., Potempa L.A., Filep J.G., Zhao J. and Wu Y. (2009) Monomeric C-reactive protein activates endothelial cells via interaction with lipid raft microdomains. FASEB J. (in press).
13. Ji S.R., Wu Y., Potempa L.A., Liang Y.H. and Zhao J. (2006). Effect of modified CRP on complement activation. A possible complement regulatory role of modified or monomeric CRP in atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 26, 935-941.
14. Ji S.R., Wu Y., Potempa L.A., Sheng F.L., Lu W. and Zhao J. (2007). Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate mCRPm. FASEB J. 21, 284-294.
15. Khreiss T., Jozsef L., Potempa L.A. and Filep J.G. (2004). Conformational rearrangement in CRP is required for proinflammatory actions on endothelial cells. Circulation 109, 2016-2022.
16. Krupinski J., Turu M.M., Slevin M. and Martínez-González J. (2007). Carotid plaque, stroke pathogenesis and CRP treatment of ischaemic stroke. Curr. Treat. Options.Cardiovasc. Med. 9, 229-235.
17. Liang Y.J., Shyu K.G., Wang B.W. and Lai L.P. (2006). C-reactive protein activates nuclear factor-ÎB pathway and induces vascular cell adhesion molecule-1 expression through CD32 in human umbilical vein endothelial cells and aortic endothelial cells. J. Mol. Cell. Cardiol. 40, 412-420.
18. Liu C., Wang S., Deb A., Nath K.A., Katusic Z.S., McConnell J.P. and Caplice N.M. (2005) Proapoptotic, antimigratory, antiproliferative, and antiangiogenic effects of commercial C-reactive protein on various human endothelial cell types in vitro: implications of contaminating presence of sodium azide in commercial preparation. Circ. Res. 97, 135-143.
19. Molins B., Pena E., Vilahur G., Mendieta C., Slevin M. and Badimon L. (2008). C-Reactive Protein Isoforms Differ in their Effects on Thrombus Growth. Thromb. Haemost. 28, 2239-2246.
20. Montero I., Orbe J., Varo N., Beloqui O., Monreal J.I., Rodriquez J.A., Diez J., Libby P. and Paramo J.A. (2006). C-reactive protein induces matrix metalloproteinase-1 and 10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. J. Am. Coll. Cardiol. 47, 1369-1378.
21. Pepys M.B., Hirschfield G.M., Tennent G.A., Gallimore J.R., Kahan M.C., Bellotti V., Hawkins P.N., Myers R.M., Smith M.D., Polara A., Cobb A.J., Ley S.V., Aquilina J.A., Robinson C.V., Sharif I., Gray G.A., Sabin C.A., Jenvey M.C., Kolstoe S.E., Thompson D. and Wood S.P. (2006). Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440, 1217-1221.
22. Ridker P.M., Cannon C.P., Morrow D., Rifai N., Rose L.M., McCabe C.H., Pfeffer M.A. and Braunwald E. (2005). C-reactive protein levels and outcomes after statin therapy. N. Engl. J. Med. 347, 1557-1565.
23. Sepulveda J.L. and Mehta J.L. (2005). CRP and cardiovascular disease. A critical appraisal. Curr. Opin. Cardiol. 20, 407-416.
24. Shah T., Casas J.P., Cooper J.A., Tzoulaki I., McCormack V., Smeeth L., Deanfield J.E., Lowe G.D., Rumley A., Fowkes F.G., Humphries SE. and Hingorani A.D. (2008). Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. Int. J. Epidemiol. (in press).
25. Slevin M., Kumar P., Gaffney J., Kumar S. and Krupinski J. (2006). Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential Clin. Sci. 111, 171-183.
26. Slevin M., Matou-Nasri., Turu M., Luque A., Rovira N., Badimon L., Boluda S., Potempa L., Sanfeliu C., de Vera N. and Krupinski J. (2009). Modified C-reactive protein is expressed in stroke neovessels and is a potent activator of angiogenesis in vitro. Brain Pathol. (in press).
27. Smith C.J., Emsley H.C., Gavin C.M., Georgiou R.F., Vail A., Barberan E.M., delZoppo G.H., Hallenbeck J.M., Rothwell N.J., Hopkins S.J. and Tyrell P.J. (2004). Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stoke correlate with brain infarct volume. BMC Neurol. 4, 2.
28. Taylor K.E., Giddings J.C. and van den Berg C.W. (2005). C-reactive protein-induced in vitro endothelial cellactivation is an artifact caused by azide and lipopolysaccharide. Arterioscler. Thromb. Vasc. Biol. 25, 1225-1230.
29. Turu M.M., Slevin M., Matou S., Badimon L. and Krupinski J. (2008). Creactive protein exerts its angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression. BMC Cell Biol. (in press).
30. Venugopal S.K., Devaraj S. and Jialal I. (2005). Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects. Am. J. Pathol. 166, 1265-1271.
31. Vilahur G., Hernandez-Vera R., Molins B., Casani L., Duran X., Padro T. and Badimon L. (2008). Short-term myocardial ischemia induces cardiac mCRP expression and pro-inflammatory gene (Cox-2, MCP- 1 and TF) up-regulation in peripheral blood mononuclear cells. J. Thromb. Haemost. (in press).
32. Xu J.W., Morita I., Ikeda K., Miki T. and Yamori Y. (2007). C-reactive protein suppresses insulin signaling in endothelial cells: role of spleen tyrosine kinase. Mol. Endocrinol. 21, 564-573.
33. Zhong Y., Li S.H., Liu S.M., Szmitko P.E., He X.Q., Fedak P.W.M. and Verma S. (2006). C-reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells. Hypertension 48, 504-511.